TONMYA is now available by prescription and available for pharmacy ordering nationwideTONMYA is the first FDA-approved treatment for fibromyalgia ...

TONMYA was approved by the FDA on August 15, 2025.

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

Tonix prepares for the November 2025 launch of Tonmya with 3Q25 revenue growth, strong cash, higher SG&A, and a robust ...

TONMYA (cyclobenzaprine HCl sublingual tablets) is a non-opioid analgesic taken once daily at bedtime for adults with fibromyalgia. The treatment was approved by the FDA on August 15, 2025, marking ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected ...

Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics. Company acquisitions: •Completed ...